Pfizer Inc. has announced the approval of Penbraya, an innovative five-in-one vaccine by the U.S. Food and Drug Administration. This groundbreaking vaccine is designed to protect teenagers and young adults against meningococcal disease, a rare but potentially fatal illness that mostly affects babies and adolescents. Comprehensive Protection in a Single Shot Penbraya offers … [Read more...] about Pfizer Introduces Penbraya: The First Five-in-One Meningococcal Vaccine
Footer
